Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Merck researchers claim new tyrosine kinase regulators and their use

July 29, 2004

Promising antitumor activity reported for DRF-1042 in patients with refractory solid tumors

July 28, 2004

PBI-1402: a hematopoietic growth stimulant and chemoprotective agent

July 28, 2004

Korean team describes antitumor agents targeting Wnt-signaling pathways

July 28, 2004

Novel protein kinase inhibitors and their use in cancer therapy

July 27, 2004

DMAG enters phase I

July 26, 2004

Access updates progress of AP-5346

July 26, 2004

FDA to grant additional six months pediatric exclusivity to clofarabine

July 26, 2004

Celera Genomics and Seattle Genetics to develop antibody therapies for cancer

July 26, 2004

TGF-beta inhibitors described in patent literature

July 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...